These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15468463)

  • 1. Corrigendum to "gender in obsessive-compulsive disorder: clinical and genetic findings" [Eur. Neuropsychopharmacol. 14 (2004) 105-113].
    Lochner C; Hemmings SM; Kinnear CJ; Moolman-Smook JC; Corfield VA; Knowles JA; Niehaus DJ; Stein DJ
    Eur Neuropsychopharmacol; 2004 Oct; 14(5):437-45. PubMed ID: 15468463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender in obsessive-compulsive disorder: clinical and genetic findings.
    Lochner C; Hemmings SM; Kinnear CJ; Moolman-Smook JC; Corfield VA; Knowles JA; Niehaus DJ; Stein DJ
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):105-13. PubMed ID: 15013025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates.
    Lochner C; Hemmings SM; Kinnear CJ; Niehaus DJ; Nel DG; Corfield VA; Moolman-Smook JC; Seedat S; Stein DJ
    Compr Psychiatry; 2005; 46(1):14-9. PubMed ID: 15714189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder.
    Camarena B; Rinetti G; Cruz C; Gómez A; de La Fuente JR; Nicolini H
    Am J Med Genet; 2001 Apr; 105(3):279-82. PubMed ID: 11353450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder.
    Karayiorgou M; Sobin C; Blundell ML; Galke BL; Malinova L; Goldberg P; Ott J; Gogos JA
    Biol Psychiatry; 1999 May; 45(9):1178-89. PubMed ID: 10331110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hoarding in obsessive-compulsive disorder: clinical and genetic correlates.
    Lochner C; Kinnear CJ; Hemmings SM; Seller C; Niehaus DJ; Knowles JA; Daniels W; Moolman-Smook JC; Seedat S; Stein DJ
    J Clin Psychiatry; 2005 Sep; 66(9):1155-60. PubMed ID: 16187774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociative experiences in obsessive-compulsive disorder and trichotillomania: clinical and genetic findings.
    Lochner C; Seedat S; Hemmings SM; Kinnear CJ; Corfield VA; Niehaus DJ; Moolman-Smook JC; Stein DJ
    Compr Psychiatry; 2004; 45(5):384-91. PubMed ID: 15332202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serotonin-1Dbeta receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosa.
    Levitan RD; Kaplan AS; Masellis M; Basile VS; Richter MA; Kennedy JL
    Eur Neuropsychopharmacol; 2006 Jan; 16(1):1-6. PubMed ID: 15944142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5HT1Dbeta Receptor gene implicated in the pathogenesis of Obsessive-Compulsive Disorder: further evidence from a family-based association study.
    Mundo E; Richter MA; Zai G; Sam F; McBride J; Macciardi F; Kennedy JL
    Mol Psychiatry; 2002; 7(7):805-9. PubMed ID: 12192628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COMT and MAO-A polymorphisms and obsessive-compulsive disorder: a family-based association study.
    Sampaio AS; Hounie AG; Petribú K; Cappi C; Morais I; Vallada H; do Rosário MC; Stewart SE; Fargeness J; Mathews C; Arnold P; Hanna GL; Richter M; Kennedy J; Fontenelle L; de Bragança Pereira CA; Pauls DL; Miguel EC
    PLoS One; 2015; 10(3):e0119592. PubMed ID: 25793616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; Landman AD; van Kempen GM
    J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.
    McGregor NW; Hemmings SMJ; Erdman L; Calmarza-Font I; Stein DJ; Lochner C
    Psychiatry Res; 2016 Dec; 246():527-532. PubMed ID: 27821364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbid obsessive-compulsive personality disorder in obsessive-compulsive disorder (OCD): a marker of severity.
    Lochner C; Serebro P; van der Merwe L; Hemmings S; Kinnear C; Seedat S; Stein DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1087-92. PubMed ID: 21411045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option.
    Lennertz L; Wagner M; Grabe HJ; Franke PE; Guttenthaler V; Rampacher F; Schulze-Rauschenbach S; Vogeley A; Benninghoff J; Ruhrmann S; Pukrop R; Klosterkötter J; Falkai P; Maier W; Mössner R
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):86-94. PubMed ID: 23928294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom dimensions, clinical course and comorbidity in men and women with obsessive-compulsive disorder.
    Torresan RC; Ramos-Cerqueira AT; Shavitt RG; do Rosário MC; de Mathis MA; Miguel EC; Torres AR
    Psychiatry Res; 2013 Sep; 209(2):186-95. PubMed ID: 23298952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Polymorphism of the Serotonin Transporter Gene, SLC6A4 rs16965628, Is Associated with Obsessive Compulsive Disorder.
    Cengiz M; Okutan SN; Bayoglu B; Sakalli Kani A; Bayar R; Kocabasoglu N
    Genet Test Mol Biomarkers; 2015 May; 19(5):228-34. PubMed ID: 25751280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) influences age at onset of obsessive-compulsive disorder.
    Lennertz L; Franke PE; Grabe HJ; Rampacher F; Schulze-Rauschenbach S; Guttenthaler V; Ruhrmann S; Pukrop R; Klosterkötter J; Falkai P; Maier W; Wagner M; Mössner R
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1951-8. PubMed ID: 23680103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study between MAO-A gene promoter VNTR polymorphisms and obsessive-compulsive disorder.
    Liu S; Yin Y; Wang Z; Zhang X; Ma X
    J Anxiety Disord; 2013 May; 27(4):435-7. PubMed ID: 23746491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder.
    Erdal ME; Tot S; Yazici K; Yazici A; Herken H; Erdem P; Derici E; Camdeviren H
    Depress Anxiety; 2003; 18(1):41-5. PubMed ID: 12900951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of association studies in obsessive-compulsive disorder.
    Hemmings SM; Stein DJ
    Psychiatr Clin North Am; 2006 Jun; 29(2):411-44. PubMed ID: 16650716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.